Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-01-02

FDA Approved: NICOTINE TRANSDERMAL SYSTEM — Supplemental Application (Dr. Reddys Laboratories Inc.)

View source ↗

Summary

FDA approved a supplemental application for the Nicotine Transdermal System from Dr. Reddys Laboratories Inc. under NDA 020076. The action relates to changes ap…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nicotine Transdermal System (Nicotine)

Snippet

SUPPL AP for NICOTINE TRANSDERMAL SYSTEM (NICOTINE)